LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

Search

Crescent Biopharma Inc

Închisă

SectorSănătate

12.5 -2.65

Rezumat

Modificarea prețului

24h

Curent

Minim

12.06

Maxim

12.85

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+97.68% upside

Dividende

By Dow Jones

Următoarele câștiguri

11 nov. 2025

Sentimentul știrilor

By Acuity

50%

50%

156 / 371 Clasament în Healthcare

Crescent Biopharma Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

9 sept. 2025, 23:37 UTC

Acțiuni populare

Stocks to Watch: Oracle, Wearable Devices, GameStop

9 sept. 2025, 20:41 UTC

Câștiguri

Oracle's Backlog Surges With Major Customer Deals in 1Q

9 sept. 2025, 20:30 UTC

Câștiguri

GameStop 2Q Sales, Profit Rise

9 sept. 2025, 23:19 UTC

Market Talk

ANZ Adds a Further 50 Bps in FOMC Cuts to Outlook -- Market Talk

9 sept. 2025, 21:35 UTC

Câștiguri

Oracle Stock Soars on Strong AI Backlog. Earnings Were Good Enough. -- Barrons.com

9 sept. 2025, 21:32 UTC

Câștiguri

Oracle's Backlog Swells With Big Customer Deals -- Update

9 sept. 2025, 21:02 UTC

Achiziții, Fuziuni, Preluări

DHL Adds to Healthcare Logistics Services With Acquisition -- Update

9 sept. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 sept. 2025, 20:33 UTC

Câștiguri

These Stocks Moved the Most Today: Apple, UnitedHealth, Nebius, Wolfspeed, Tourmaline Bio, Albemarle, Dell, and More -- Barrons.com

9 sept. 2025, 20:26 UTC

Câștiguri

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9 sept. 2025, 20:23 UTC

Câștiguri

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9 sept. 2025, 20:12 UTC

Câștiguri

Oracle Stock Jumps on Mixed Earnings Report -- Barrons.com

9 sept. 2025, 20:10 UTC

Câștiguri

Oracle Expects Cloud Infrastructure Rev to Grow 77% to $18 B This Fiscal Yr >ORCL

9 sept. 2025, 20:10 UTC

Câștiguri

Oracle Expects to Sign-Up Several Additional Multi-B-dollar Customers and RPO Is Likely to Exceed Half-A-Trillion Dollars Over Next Few Mos

9 sept. 2025, 20:09 UTC

Câștiguri

Synopsys Sees 4Q Adj EPS $2.76-Adj EPS $2.80 >SNPS

9 sept. 2025, 20:09 UTC

Câștiguri

Synopsys Sees 4Q Loss/Shr 16c-Loss 27c >SNPS

9 sept. 2025, 20:08 UTC

Câștiguri

Oracle 1Q Short-term Deferred Rev Were $12.1 B >ORCL

9 sept. 2025, 20:08 UTC

Câștiguri

Oracle 1Q Operating Income Was $4.3 B >ORCL

9 sept. 2025, 20:08 UTC

Câștiguri

Oracle Expects MultiCloud Rev to Grow Substantially Every Qtr for Several Years >ORCL

9 sept. 2025, 20:08 UTC

Câștiguri

Synopsys Sees 4Q Rev $2.23B-$2.26B >SNPS

9 sept. 2025, 20:07 UTC

Câștiguri

Oracle Total Remaining Performance Obligations Up to $455 B >ORCL

9 sept. 2025, 20:06 UTC

Câștiguri

Oracle 1Q Software Revenue $5.72B >ORCL

9 sept. 2025, 20:06 UTC

Câștiguri

Synopsys 3Q Adj EPS $3.39 >SNPS

9 sept. 2025, 20:06 UTC

Câștiguri

Oracle 1Q Cloud Revenue $7.19B >ORCL

9 sept. 2025, 20:05 UTC

Câștiguri

Oracle 1Q Rev $14.93B >ORCL

9 sept. 2025, 20:05 UTC

Câștiguri

Oracle 1Q EPS $1.01 >ORCL

9 sept. 2025, 20:05 UTC

Câștiguri

Synopsys 3Q EPS $1.50 >SNPS

9 sept. 2025, 20:05 UTC

Câștiguri

Oracle 1Q Services Revenue $1.35B >ORCL

9 sept. 2025, 20:05 UTC

Câștiguri

Oracle 1Q Adj EPS $1.47 >ORCL

9 sept. 2025, 20:05 UTC

Câștiguri

Oracle 1Q Hardware Revenue $670M >ORCL

Comparație

Modificare preț

Crescent Biopharma Inc Așteptări

Obiectiv de preț

By TipRanks

97.68% sus

Prognoză pe 12 luni

Medie 25.6 USD  97.68%

Maxim 28 USD

Minim 22 USD

În baza a 6 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruCrescent Biopharma Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

6 ratings

6

Cumpărare

0

Păstrare

0

Vânzare

Sentiment

By Acuity

156 / 371 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

$

help-icon Live chat